A new trading day began on Friday, with Biodesix Inc (NASDAQ: BDSX) stock price up 7.49% from the previous day of trading, before settling in for the closing price of $0.28. BDSX’s price has ranged from $0.17 to $2.04 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 23.77%. Meanwhile, its annual earnings per share averaged 26.46%. With a float of $69.40 million, this company’s outstanding shares have now reached $146.44 million.
The extent of productivity of a business whose workforce counts for 273 workers is very important to gauge. In terms of profitability, gross margin is 78.38%, operating margin of -43.71%, and the pretax margin is -54.28%.
Biodesix Inc (BDSX) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Diagnostics & Research Industry. The insider ownership of Biodesix Inc is 52.65%, while institutional ownership is 36.42%. The most recent insider transaction that took place on May 16 ’25, was worth 1,070,000. In this transaction Director of this company bought 4,000,000 shares at a rate of $0.27, taking the stock ownership to the 20,194,935 shares. Before that another transaction happened on May 19 ’25, when Company’s Director bought 723,239 for $0.34, making the entire transaction worth $246,624. This insider now owns 20,918,174 shares in total.
Biodesix Inc (BDSX) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 26.46% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 33.97% during the next five years compared to 69.26% growth over the previous five years of trading.
Biodesix Inc (NASDAQ: BDSX) Trading Performance Indicators
Here are Biodesix Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.14. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.60.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.29, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.15 in one year’s time.
Technical Analysis of Biodesix Inc (BDSX)
The latest stats from [Biodesix Inc, BDSX] show that its last 5-days average volume of 1.72 million was inferior to 5.14 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 23.87%. Additionally, its Average True Range was 0.06.
During the past 100 days, Biodesix Inc’s (BDSX) raw stochastic average was set at 12.05%, which indicates a significant decrease from 18.73% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 182.16% in the past 14 days, which was higher than the 141.44% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.4557, while its 200-day Moving Average is $1.1219. Now, the first resistance to watch is $0.3169. This is followed by the second major resistance level at $0.3310. The third major resistance level sits at $0.3519. If the price goes on to break the first support level at $0.2819, it is likely to go to the next support level at $0.2610. Assuming the price breaks the second support level, the third support level stands at $0.2469.
Biodesix Inc (NASDAQ: BDSX) Key Stats
With a market capitalization of 44.39 million, the company has a total of 146,563K Shares Outstanding. Currently, annual sales are 71,320 K while annual income is -42,930 K. The company’s previous quarter sales were 17,960 K while its latest quarter income was -11,100 K.
